Main Session
Sep
28
SS 03 - GU 1: Advances in Localized Prostate Cancer
Primary results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Presenter(s)
Rodney Ellis, - University of South Florida/Tampa GeneralHospital, Tampa, FL